Product
Camonsertib
2 clinical trials
3 indications
Indication
Solid TumorsIndication
cancerIndication
Non-Small Cell LungClinical trial
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform TrialStatus: Recruiting, Estimated PCD: 2032-09-25
Clinical trial
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Non-Small Cell Lung Cancer (Morpheus-Lung)Status: Active (not recruiting), Estimated PCD: 2025-09-30